We discovered nine patients in our cohort who had congenital thrombophilia; there were eight heterozygous mutations of the prothrombin gene and one heterozygous factor V gene mutation, two patients had protein C deficiency, and one had antithrombin deficiency. This evidence concerns the gene F2 and hereditary antithrombin deficiency.